Evaluation of the prevalence of anxiety and depression and theimpact of asthma control level on these parameters amongasthmatic patients
Main Article Content
Keywords
act, asthma-related anxiety, asthma-related depression, gag-7 score, phq-9 score
Abstract
Objectives: This study is designed to assess the prevalence of anxiety and depression among asthmatic patients living in Amman, Jordan. Additionally, it evaluates the effect of asthma control levels using the correct inhaler technique on anxiety and depression. Method: This single-blinded, randomized, interventional, active-control study was conducted at the University of Jordan Hospital in the period between March and August of 2019. Asthmatic patients in the active group were counseled on the correct inhaler technique using placebo inhalers and using sticky labels on their prescribed inhalers. At the baseline and after three months, both groups were assessed on their asthma level of control, anxiety and depression using the asthma control test (ACT), general anxietya disorder (GAD-7) and patient health questionnaire (PHQ-9), respectively. A total of 159 asthmatic adult patients were recruited and randomized into active groups (n = 79) and control groups (n = 78) using controller inhalers, either Turbohaler or Accuhaler or both. Results: ACT, GAD7, and PHQ9 were assessed at the baseline and no statistically significant difference between both groups was found (P-value < 0.001). At follow-up, ACT, GAD7, and PHQ9 showed significant differences in the active group with mean ± SD of 21.21±5.26, (P-value < 0.001), 3.84 ±4.782, (P-value < 0.001), 6.4±6.4115, (P-value < 0.001), respectively. At the same time, the difference in the mean score for control group patients did not reach a significant level. Conclusion: The prevalence of psychological disorders among asthmatic patients is common and directly related to the asthma level of control. Improvements in the ACT can lead to significant improvements in patient anxiety and depression related to asthma.
References
2. Barnes P, Drazen J. Pathophysiology of asthma. Asthma and COPD
3. Zhou X, Li J, Gu W, et al. Prevalence and associated factors of anxiety and depression among patients with chronic respiratory diseases in eight general hospitals in Jiangsu Province of China: a cross-sectional study. Psychiatry research. 2017;251:48-53.https://doi.org/10.1016/j.psychres.2017.01.070
4. Sundbom F, Malinovschi A, Lindberg E, et al. Effects of poor asthma control, insomnia, anxiety and depression on quality of lifenin young asthmatics. J Asthma. 2016;53(4):398-403. https://doi.org/10.3109/02770903.2015.1126846
5. van Boven JF, Ryan D, Eakin MN, et al. Enhancing respiratory medication adherence: the role of health care professionals and cost-effectiveness considerations. The Journal of Allergy and Clinical Immunology: In Practice. 2016;4(5):835-846. https://doi.org/10.1016/j.jaip.2016.03.007
6. Adeyeye OO, Adewumi TA, Adewuya AO. Effect of psychological and other factors on quality of life amongst asthma outpatients in Lagos, Nigeria. Respiratory medicine. 2017;122:67-70. https://doi.org/10.1016/j.rmed.2016.12.002
7. Fernandes L, Fonseca J, Martins S, et al. Association of anxiety with asthma: subjective and objective outcome measures. Psychosomatics. 2010;51(1):39-46. https://doi.org/10.1176/appi.psy.51.1.39
8. Di Marco F, Verga M, Santus P, et al. Close correlation between anxiety, depression, and asthma control. Respiratory medicine.2010;104(1):22-28. https://doi.org/10.1016/j.rmed.2009.08.005
9. Yang CJ, Liu D, Xu ZS, et al. The pro-inflammatory cytokines, salivary cortisol and alpha-amylase are associated with generalized anxiety disorder (GAD) in patients with asthma. Neurosci Lett. 2017;656:15-21. https://doi.org/10.1016/j.neulet.2017.07.021
10. Ciprandi G, Schiavetti I, Rindone E, et al. The impact of anxiety and depression on outpatients with asthma. Annals of allergy, asthma & immunology. 2015;115(5):408-414. https://doi.org/10.1016/j.anai.2015.08.007
11. Basheti IA, Bosnic-Anticevich SZ, Armour CL, et al. Checklists for powder inhaler technique: a review and recommendations.Respiratory care. 2014;59(7):1140-1154. https://doi.org/10.4187/respcare.02342
12. Lababidi H, Hijaoui A, Zarzour M. Validation of the Arabic version of the asthma control test. Annals of thoracic medicine.2008;3(2):44. https://doi.org/10.4103/1817-1737.39635
13. Sawaya H, Atoui M, Hamadeh A, et al. Adaptation and initial validation of the Patient Health Questionnaire–9 (PHQ-9) and the Generalized Anxiety Disorder–7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry research. 2016;239:245-252. https://doi.org/10.1016/j.psychres.2016.03.030
14. Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the World Mental Health Survey. General hospital psychiatry. 2007;29(2):123-133. https://doi.org/10.1016/j.genhosppsych.2006.12.006
15. Del Giacco SR, Cappai A, Gambula L, et al. The asthma-anxiety connection. Respir Med. 2016;120:44-53. https://doi.org/10.1016/j.rmed.2016.09.014
16. Amelink M, Hashimoto S, Spinhoven P, et al. Anxiety, depression and personality traits in severe, prednisone-dependent asthma. Respir Med. 2014;108(3):438-444. https://doi.org/10.1016/j.rmed.2013.12.012
17. Opolski M, Wilson I. Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clinical Practice and Epidemiology in Mental Health. 2005;1(1):18. https://doi.org/10.1186/1745-0179-1-18
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.